Table of Contents Table of Contents 2 List of Tables 3 List of Figures 4 Report Guidance 5 Clinical Trials by Region 6 Clinical Trials and Average Enrollment by Country 7 Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10 Top Five Countries Contributing to Clinical Trials in Europe 11 Top Countries Contributing to Clinical Trials in North America 12 Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13 Top Five Countries Contributing to Clinical Trials in Central and South America 14 Clinical Trials by G7 Countries: Proportion of Ocular Hypertension to Ophthalmology Clinical Trials 15 Clinical Trials by Phase in G7 Countries 16 Clinical Trials in G7 Countries by Trial Status 17 Clinical Trials by E7 Countries: Proportion of Ocular Hypertension to Ophthalmology Clinical Trials 18 Clinical Trials by Phase in E7 Countries 19 Clinical Trials in E7 Countries by Trial Status 20 Clinical Trials by Phase 21 In Progress Trials by Phase 22 Clinical Trials by Trial Status 23 Clinical Trials by End Point Status 24 Subjects Recruited Over a Period of Time 25 Clinical Trials by Sponsor Type 26 Prominent Sponsors 27 Top Companies Participating in Ocular Hypertension Therapeutics Clinical Trials 28 Prominent Drugs 30 Latest Clinical Trials News on Ocular Hypertension 31 Mar 17, 2016: Aerie Pharmaceuticals Reports Update on Positive Safety Results for Rhopressa QD (netarsudil ophthalmic solution) 0.02% 31 Mar 03, 2016: Aerie Pharmaceuticals Announces Availability on Its Website of Abstracts to be Presented at the American Glaucoma Society 26th Annual Meeting 32 Feb 17, 2016: Aerie Pharmaceuticals Reports Positive Rhopressa QD (netarsudil ophthalmic solution) 0.02% 12 Month Interim Safety Results for Rocket 2 32 Feb 16, 2016: Ocular Therapeutix Announces Phase 3 Clinical Development Plan for OTX-TP, an Innovative Therapy for Glaucoma and Ocular Hypertension 33 Clinical Trial Profile Snapshots 35 Appendix 367 Abbreviations 367 Definitions 367 Research Methodology 368 Secondary Research 368 About GlobalData 369 Contact Us 369 Disclaimer 369 Source 370

List of Tables Ocular Hypertension Therapeutics, Global, Clinical Trials by Region, 2016* 6 Ocular Hypertension Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 8 Ocular Hypertension Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 9 Ocular Hypertension Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2016* 10 Ocular Hypertension Therapeutics Clinical Trials, Europe, Top Five Countries, 2016* 11 Ocular Hypertension Therapeutics Clinical Trials, North America, Top Countries, 2016* 12 Ocular Hypertension Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2016* 13 Ocular Hypertension Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2016* 14 Proportion of Ocular Hypertension to Ophthalmology Clinical Trials, G7 Countries (%), 2016* 15 Ocular Hypertension Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 16 Ocular Hypertension Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 17 Proportion of Ocular Hypertension to Ophthalmology Clinical Trials, E7 Countries (%), 2016* 18 Ocular Hypertension Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 19 Ocular Hypertension Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 20 Ocular Hypertension Therapeutics, Global, Clinical Trials by Phase, 2016* 21 Ocular Hypertension Therapeutics, Global, Clinical Trials In Progress by Phase 2016* 22 Ocular Hypertension Therapeutics, Global, Clinical Trials by Trial Status, 2016* 23 Ocular Hypertension Therapeutics Clinical Trials, Global, by End Point Status, 2016* 24 Ocular Hypertension Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 25 Ocular Hypertension Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2016* 26 Ocular Hypertension Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 27 Ocular Hypertension Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 29 Ocular Hypertension Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 30 List of Figures Ocular Hypertension Therapeutics, Global, Clinical Trials by Region (%), 2016* 6 Ocular Hypertension Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7 Ocular Hypertension Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 9 Ocular Hypertension Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2016* 10 Ocular Hypertension Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2016* 11 Ocular Hypertension Therapeutics Clinical Trials, North America, Top Countries (%), 2016* 12 Ocular Hypertension Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2016* 13 Ocular Hypertension Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2016* 14 Proportion of Ocular Hypertension to Ophthalmology Clinical Trials, G7 Countries (%), 2016* 15 Ocular Hypertension Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 16 Ocular Hypertension Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 17 Proportion of Ocular Hypertension to Ophthalmology Clinical Trials, E7 Countries (%), 2016* 18 Ocular Hypertension Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 19 Ocular Hypertension Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 20 Ocular Hypertension Therapeutics, Global, Clinical Trials by Phase (%), 2016* 21 Ocular Hypertension Therapeutics, Global, Clinical Trials In Progress by Phase, 2016* 22 Ocular Hypertension Therapeutics, Global, Clinical Trials by Trial Status, 2016* 23 Ocular Hypertension Therapeutics Clinical Trials, Global, by End Point Status, 2016* 24 Ocular Hypertension Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 25 Ocular Hypertension Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2016* 26 Ocular Hypertension Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 27 Ocular Hypertension Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 28 Ocular Hypertension Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 30 GlobalData Methodology 368

Novartis AG Allergan Plc Pfizer Inc. Santen Pharmaceutical Co., Ltd. Aerie Pharmaceuticals, Inc. Valeant Pharmaceuticals International, Inc. Merck & Co., Inc. Kowa Company, Ltd. Mati Therapeutics Inc. QLT Inc.